NCT04892758View on ClinicalTrials.gov

Replication of the P04334 Asthma Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

10,288

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions
Asthma
Interventions
DRUG

Formoterol fumarate 10 mcg

Formoterol fumarate 10 mcg dispensing claim is used as the reference group.

DRUG

Mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID

Mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID dispensing claim is used as the exposure group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04892758 - Replication of the P04334 Asthma Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter